Twist Bioscience Corp at Cowen Health Care Conference (Virtual) - Fireside Chat Transcript
All right. Good afternoon, everyone. I'm Steve Mah, the newest member of Cowen's tools and diagnostics research team joining Dan Brennan and Max Masucci. (Conference Instructions)
So it's our pleasure to welcome Emily Leproust and Jim Thorburn from Twist Bioscience to our conference. I think most people know Twist. So I think we'll forego the company introduction and just jump right into the fireside chat session. So today, we're going to focus on outlook for 2022, progress across the base business, pipeline development, and maybe some of your philosophy on some of your business decisions and how you see Twist evolving over the next three to five years.
Thanks for having us.
Questions & Answers
Okay. All right. So yeah, so first question, maybe we'll start from a high level first and then drill down later. But as I've known Twist for a long
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |